[Multicentre clinical observation of anticoagulation and thrombolysis for the deep venous thrombosis]

Author(s): Wang HT, Jiang WL, Zhang YN, Sun ZF, Sun QF, Ma J

Affiliation(s): Harbin Medical University, Harbin 150086, China.

Publication date & source: 2009-12-08, Zhonghua Yi Xue Za Zhi., 89(45):3181-5.

Publication type: English Abstract; Multicenter Study; Randomized Controlled Trial

OBJECTIVE: Multicentre clinical observation for therapeutic efficacy and clinical safety of anticoagulation and thrombolysis in deep venous thrombosis (DVT). METHODS: 127 patients with DVT in left leg were randomly divided into four groups. Group A: treated with batroxobin. Group B: use Low Molecular Weight Heparin (LMWH). Group C: batroxobin and LMWH. Group D: urokinase and LMWH. Observing the perimeter of thigh and calf periodically, monitoring coagulation function, registering the frequency and degree of the complication. RESULTS: All the treatments in four groups can relieve the swell level of the affected legs (P < 0.05). We got the best efficacy when we use batroxobin together with LMWH (P < 0.05), especially in treating the patients with a long course of treatment. Batroxobin can obviously reduce the level of blood FBG (P < 0.05), and have no significant effect with other index of coagulation function (P > 0.05). Inject ing batroxobin into affected legs with the micro pump got a better efficacy and much safer than intravenously guttae from peripheral vein. CONCLUSION: Treating DVT with batroxobin got a definite efficacy, especially in cases with a long course of treatment; micro pumping can give a better effect and a high safety.